Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Could a temperature-resistant vaccine spell the end for rabies and yellow fever?

Current vaccines for rabies and yellow fever are plagued by the difficulties of transporting temperature-controlled drugs. A new European consortium led by KU Leuven may have the solution. Elly Earls reports.

Go Top